Skip to main content
Ziho Lee, MD, Urology, Chicago, IL

ZihoLeeMD

Urology Chicago, IL

Minimally Invasive Surgery, Trauma & Reconstructive Surgery

Physician

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    675 N Saint Clair St
    Ste 20-150
    Chicago, IL 60611
    Phone+1 312-695-8146
    Fax+1 312-695-7030

Education & Training

  • Temple University Hospital
    Temple University HospitalResidency, Urology, 2015 - 2019
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2014

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2021 - 2026
  • WA State Medical License
    WA State Medical License 2020 - 2023
  • PA State Medical License
    PA State Medical License 2014 - 2021

Publications & Presentations

PubMed

Authored Content

  • Minerva Urologica E Nefrologica 2018 June;70(3):231-41November 2018

Press Mentions

  • ASCO GU 2020: The SEMITEP Trial: De-Escalating Chemotherapy in Low-Volume Metastatic Seminoma Based on Early FDG-PET
    ASCO GU 2020: The SEMITEP Trial: De-Escalating Chemotherapy in Low-Volume Metastatic Seminoma Based on Early FDG-PETFebruary 17th, 2020
  • ASCO GU 2020: Overall Survival Results for Durvalumab and Savolitinib in Metastatic Papillary Renal Cancer
    ASCO GU 2020: Overall Survival Results for Durvalumab and Savolitinib in Metastatic Papillary Renal CancerFebruary 17th, 2020
  • ASCO GU 2020: Prospective Observational Study on Pazopanib in Patients Treated for Advanced/Metastatic Renal Cell Carcinoma: APOLON Study
    ASCO GU 2020: Prospective Observational Study on Pazopanib in Patients Treated for Advanced/Metastatic Renal Cell Carcinoma: APOLON StudyFebruary 17th, 2020
  • Join now to see all

Other Languages

  • Korean